# FDA Inspection 1125668 - Adam S. Giermasz, M.D., Ph.D. - July 17, 2020

Source: https://www.globalkeysolutions.net/records/fda_inspections/adam-s-giermasz-md-phd/e0f24201-4bce-4322-a7d0-8ee93a80518a/
Source feed: FDA_Inspections

> FDA Inspection 1125668 for Adam S. Giermasz, M.D., Ph.D. on July 17, 2020. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1125668
- Company Name: Adam S. Giermasz, M.D., Ph.D.
- Inspection Date: 2020-07-17
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1125668 - 2020-07-17](https://www.globalkeysolutions.net/api/records/fda_inspections/adam-s-giermasz-md-phd/b2111331-6fdc-4ab9-9d17-aeac053d0d0f/)
- [FDA Inspection 1065837 - 2018-08-16](https://www.globalkeysolutions.net/api/records/fda_inspections/adam-s-giermasz-md-phd/d534c48e-ee30-42ee-b20c-6cfbf35eadb8/)

Company: https://www.globalkeysolutions.net/companies/adam-s-giermasz-md-phd/bcc67ec3-cb56-4ad3-a4db-8ec362cceff5

Office: https://www.globalkeysolutions.net/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d